Key result
Custom AAV1-T593K variant improves quail neuron transduction efficiency ~5-fold versus wild-type AAV1.
Why the study?
Viral vectors optimized in rodents are less efficient in birds, limiting the use of genetically-encoded tools and methods in avian models.
A custom-designed AAV1 variant (AAV1-T593K) significantly improves the transduction efficiency of Japanese quail neurons in vitro and in vivo, enabling genetic manipulation in this avian model.
Answers are grounded in this paper and cite their sources.
Enables efficient genetic manipulation in quail models; extends AAV engineering to avian neurons but leaves translation open.
The widespread use of rodents in neuroscience has prompted the development of optimized viral variants for transduction of brain cells, in vivo. However, many of the viruses developed are less efficient in other model organisms, with birds being among the most resistant to transduction by current viral tools. Resultantly, the use of genetically-encoded tools and methods in avian species is markedly lower than in rodents; likely holding the field back. We sought to bridge this gap by developing custom viruses towards the transduction of brain cells of the Japanese quail. We first develop a protocol for culturing primary neurons and glia from quail embryos, followed by characterization of cultures via immunostaining, single cell mRNA sequencing, patch clamp electrophysiology and calcium imaging. We then leveraged the cultures for the rapid screening of various viruses, only to find that all yielded poor to no infection of cells in vitro. However, few infected neurons were obtained by AAV1 and AAV2. Scrutiny of the sequence of the AAV receptor found in quails led us to rationally design a custom-made AAV variant (AAV1-T593K; AAV1*) that exhibits improved transduction efficiencies in vitro and in vivo (14- and five-fold, respectively). Together, we present unique culturing method, transcriptomic profiles of quail's brain cells and a custom-tailored AAV1 for transduction of quail neurons in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Zoabi et al. (2023) studied this question. AAV1-T593K (AAV1) vs. AAV1 was evaluated on In vivo infection efficiency (cells/mm2) (p=0.005). A custom-made AAV1 variant (AAV1-T593K) significantly improved transduction efficiency of Japanese quail neurons in vivo by approximately five-fold compared to wild-type AAV1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: